180 related articles for article (PubMed ID: 19798054)
41. Transcriptional factor AP-2gamma increases human cystatin A gene transcription of keratinocytes.
Takahashi H; Oyama N; Itoh Y; Ishida-Yamamoto A; Kaneko F; Iizuka H
Biochem Biophys Res Commun; 2000 Nov; 278(3):719-23. PubMed ID: 11095974
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome.
Jiang L; Huang J; Li L; Chen Y; Chen X; Zhao X; Yang D
J Clin Endocrinol Metab; 2015 May; 100(5):E729-38. PubMed ID: 25695884
[TBL] [Abstract][Full Text] [Related]
43. Transcription factor AP-2gamma, a novel marker of gonocytes and seminomatous germ cell tumors.
Pauls K; Jäger R; Weber S; Wardelmann E; Koch A; Büttner R; Schorle H
Int J Cancer; 2005 Jun; 115(3):470-7. PubMed ID: 15700319
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression.
Zheng B; Liu F; Zeng L; Geng L; Ouyang X; Wang K; Huang Q
Med Sci Monit; 2018 May; 24():3103-3112. PubMed ID: 29752805
[TBL] [Abstract][Full Text] [Related]
45. In vitro and in silico assessment of the effect of WWOX expression on invasiveness pathways associated with AP-2 transcription factors in bladder cancer.
Kałuzińska Ż; Kołat D; Kośla K; Orzechowska M; Bednarek AK; Płuciennik E
BMC Urol; 2021 Mar; 21(1):36. PubMed ID: 33691672
[TBL] [Abstract][Full Text] [Related]
46. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M; Quaas M; Nickel A; Engeland K
Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
[TBL] [Abstract][Full Text] [Related]
47. β-catenin regulates c-Myc and CDKN1A expression in breast cancer cells.
Xu J; Chen Y; Huo D; Khramtsov A; Khramtsova G; Zhang C; Goss KH; Olopade OI
Mol Carcinog; 2016 May; 55(5):431-9. PubMed ID: 25663530
[TBL] [Abstract][Full Text] [Related]
48. Roles of activator protein-2 gamma in breast cancer: A narrative review (SANRA).
Zhang Y; Mostafa AA; Sriboonvorakul N; Hu J
Medicine (Baltimore); 2022 Sep; 101(38):e30587. PubMed ID: 36197225
[TBL] [Abstract][Full Text] [Related]
49. Treatment effect of CDKN1A on rheumatoid arthritis by mediating proliferation and invasion of fibroblast-like synoviocytes cells.
Gang X; Xu H; Si L; Zhu X; Yu T; Jiang Z; Wang Y
Clin Exp Immunol; 2018 Nov; 194(2):220-230. PubMed ID: 29920650
[TBL] [Abstract][Full Text] [Related]
50. AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells.
Zhang X; Leung YK; Ho SM
Oncogene; 2007 Nov; 26(52):7346-54. PubMed ID: 17525739
[TBL] [Abstract][Full Text] [Related]
51. AP-2 transcription factors in the regulation of ERBB2 gene transcription by oestrogen.
Perissi V; Menini N; Cottone E; Capello D; Sacco M; Montaldo F; De Bortoli M
Oncogene; 2000 Jan; 19(2):280-8. PubMed ID: 10645007
[TBL] [Abstract][Full Text] [Related]
52. Fragile Gene
Kołat D; Kałuzińska Ż; Płuciennik E
Front Oncol; 2021; 11():621060. PubMed ID: 33718178
[TBL] [Abstract][Full Text] [Related]
53. HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma.
Li L; Zheng YL; Jiang C; Fang S; Zeng TT; Zhu YH; Li Y; Xie D; Guan XY
Cell Death Differ; 2019 Nov; 26(11):2268-2283. PubMed ID: 30778199
[TBL] [Abstract][Full Text] [Related]
54. Pleurotus ostreatus inhibits proliferation of human breast and colon cancer cells through p53-dependent as well as p53-independent pathway.
Jedinak A; Sliva D
Int J Oncol; 2008 Dec; 33(6):1307-13. PubMed ID: 19020765
[TBL] [Abstract][Full Text] [Related]
55. ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21.
Cosi I; Pellecchia A; De Lorenzo E; Torre E; Sica M; Nesi G; Notaro R; De Angioletti M
J Hematol Oncol; 2020 Aug; 13(1):112. PubMed ID: 32791988
[TBL] [Abstract][Full Text] [Related]
56. MiR-639 promoted cell proliferation and cell cycle in human thyroid cancer by suppressing CDKN1A expression.
Lei ST; Shen F; Chen JW; Feng JH; Cai WS; Shen L; Hu ZW; Xu B
Biomed Pharmacother; 2016 Dec; 84():1834-1840. PubMed ID: 27829546
[TBL] [Abstract][Full Text] [Related]
57. Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells.
Kim YC; Chen C; Bolton EC
PLoS One; 2015; 10(9):e0138286. PubMed ID: 26372468
[TBL] [Abstract][Full Text] [Related]
58. Estrogen regulated expression of the p21 Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells.
Mandal S; Davie JR
J Cell Physiol; 2010 Jul; 224(1):28-32. PubMed ID: 20301197
[TBL] [Abstract][Full Text] [Related]
59. PP2A inhibitors arrest G2/M transition through JNK/Sp1- dependent down-regulation of CDK1 and autophagy-dependent up-regulation of p21.
Gong FR; Wu MY; Shen M; Zhi Q; Xu ZK; Wang R; Wang WJ; Zong Y; Li ZL; Wu Y; Zhou BP; Chen K; Tao M; Li W
Oncotarget; 2015 Jul; 6(21):18469-83. PubMed ID: 26053095
[TBL] [Abstract][Full Text] [Related]
60. Transcription factor AP-2alpha represses both the mucin MUC4 expression and pancreatic cancer cell proliferation.
Fauquette V; Aubert S; Groux-Degroote S; Hemon B; Porchet N; Van Seuningen I; Pigny P
Carcinogenesis; 2007 Nov; 28(11):2305-12. PubMed ID: 17621592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
